Phathom Pharmaceuticals, Inc. Share Price
NASDAQ: PHAT | Small CapPhathom Pharmaceuticals, Inc. Stock Performance
Open $8.56 | Prev. Close $8.39 | Circuit Range N/A |
Day Range $8.31 - $8.57 | Year Range $8.21 - $18.25 | Volume 1,16,033 |
Average Traded $8.45 |
Phathom Pharmaceuticals, Inc. Share Price Today
As of 10 August 2026, Phathom Pharmaceuticals, Inc.'s share price is $8.56. The stock opened at $8.56, compared to its previous close of $8.39. During today's trading session, Phathom Pharmaceuticals, Inc.'s share price traded between $8.31 and $8.57, with an average price of $8.44. Over the past 52 weeks, the stock has recorded a high of $18.25 and a low of $8.21. In terms of performance, Phathom Pharmaceuticals, Inc.'s share price has declined by 31.87% over the last six months and is down 29.66% on a year-on-year basis.
Phathom Pharmaceuticals, Inc. Share Price Chart
Phathom Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $624.18M | PE Ratio (TTM) -2.83 | Dividend Yield N/A |
EPS (TTM) $-3.03 | Revenue (TTM) $175.11M | Return On Equity (TTM) 50.49% |
Profit Margin -126.35% | Debt to Equity -0.30 | Quarterly Earnings Growth YoY 64.98% |
Phathom Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Phathom Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Phathom Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $8.71 | $8.56 | -3.66% |
Jul 2026 | $10.91 | $8.88 | -18.19% |
Jun 2026 | $9.57 | $10.86 | +13.12% |
May 2026 | $11.44 | $9.60 | -13.86% |
Apr 2026 | $11.29 | $11.14 | +0.13% |
Mar 2026 | $12.09 | $11.13 | -11.42% |
Feb 2026 | $13.83 | $12.56 | -8.15% |
Jan 2026 | $16.52 | $13.68 | -17.59% |
Dec 2025 | $15.33 | $16.60 | +5.87% |
Nov 2025 | $13.51 | $15.68 | +15.63% |
Oct 2025 | $11.84 | $13.56 | +15.31% |
Sep 2025 | $11.90 | $11.76 | -3.37% |
PHAT Share Price FAQs
What is Phathom Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Phathom Pharmaceuticals, Inc. stock?
What is PHAT's market capitalisation today?
What is PHAT's net income for the last quarter?
What is the 5 year returns of PHAT?
What is the high & low stock price of PHAT today?
Can I buy PHAT shares in India?